Aztiq Pharma Partners is an investment company specializing in the pharmaceutical and biotechnology sectors, aiming to improve global healthcare. With over 100 years of cumulative experience, the company focuses on fostering growth and innovation in purpose-driven partners, executing over 50 M&A transactions valued at $10 billion, and securing over 1,000 partnerships. Aztiq is known for its flexible, collaborative approach and global reach, with 13 years in operation and $1.5 billion capital invested.
Recent Transactions involving Aztiq Pharma Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse |
Alvogen Emerging Markets Holdings |
AdalvoLotus Pharmaceuticals |
InnobicAztiq Pharma Partners |
Pharmaceutical Manufacturing |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →